This paper reports the course with respect to remission and relapse of a cohort of predominantly in-patient RDC major depressive subjects, who were followed at 3-monthly intervals to remission and for up to 15 months thereafter. Remission was comparatively rapid with 70% of subjects remitting within 6 months. Only 6% failed to do so by 15 months. However, 40% relapsed over the subsequent 15 months, with all the relapses occurring in the first 10 months. Greater severity of the depression and longer duration of the illness predicted a longer time to remission. Greater initial severity of depression also predicted relapse. Subjects with a worse outcome had not received less adequate treatment than the remainder. Our results confirm the compar...
Background Reducing the risk of relapses is a critical component of major depressive disorders treat...
There is a growing body of literature which indicates that acute phases of psychotherapy are often i...
Background Knowledge of the risk of recurrence after recovery from major depressive disorder (MDD) i...
Many individuals treated for depression suffer relapse or recurrence after treatment. Known risk fac...
Background: Despite the availability of many effective treatments, patients with major depression re...
This paper draws attention to an important adverse outcome in depression, the occurrence of residual...
Background. Few studies have examined spontaneous remission from major depression. This study invest...
OBJECTIVE: This study assessed prospectively the pattern of recurrence of illness after recovery fr...
Objective:Knowledge of the risk of recurrence after recovery of a major depressive disorder (MDD) is...
Of 3 1 6 patients with a major depressive disorder who were followed for between 6 months and 2 year...
There is a growing body of literature which indicates that acute phases of psychotherapy are often i...
In randomized controlled trials, maintenance treatment for relapse prevention has been proven to be ...
Objective: The authors studied the risk of relapse among depressed patients after cognitive behavior...
Background Reducing the risk of relapses is a critical component of major depressive disorders treat...
There is a growing body of literature which indicates that acute phases of psychotherapy are often i...
Background Knowledge of the risk of recurrence after recovery from major depressive disorder (MDD) i...
Many individuals treated for depression suffer relapse or recurrence after treatment. Known risk fac...
Background: Despite the availability of many effective treatments, patients with major depression re...
This paper draws attention to an important adverse outcome in depression, the occurrence of residual...
Background. Few studies have examined spontaneous remission from major depression. This study invest...
OBJECTIVE: This study assessed prospectively the pattern of recurrence of illness after recovery fr...
Objective:Knowledge of the risk of recurrence after recovery of a major depressive disorder (MDD) is...
Of 3 1 6 patients with a major depressive disorder who were followed for between 6 months and 2 year...
There is a growing body of literature which indicates that acute phases of psychotherapy are often i...
In randomized controlled trials, maintenance treatment for relapse prevention has been proven to be ...
Objective: The authors studied the risk of relapse among depressed patients after cognitive behavior...
Background Reducing the risk of relapses is a critical component of major depressive disorders treat...
There is a growing body of literature which indicates that acute phases of psychotherapy are often i...
Background Knowledge of the risk of recurrence after recovery from major depressive disorder (MDD) i...